Ciprofloxacin Hydrochloride/Hydrocortisone

盐酸环丙沙星/氢化可的松

Report date: 2026/03/04 20:01:44

Base Information

Drug NameCiprofloxacin Hydrochloride/Hydrocortisone
Drug Alias NameCiprofloxacin Hydrochloride●Hydrocortisone环丙沙星/氢化可的松盐酸环丙沙星和氢化可的松Ciprofloxacin Hydrochloride and Hydrocortisone盐酸环丙沙星-氢化可的松 +[13] 
ClassificationSmall molecules > SteroidsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionGlucocorticoid receptor agonistsBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors
TargetsGlucocorticoid receptorBacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsOtitis Externa
Global Approved IndicationsOtitis Externa
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/02/10
Country/TerritoryUnited StatesMainland China
CombinationsYes Ciprofloxacin HydrochlorideHydrocortisone
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSandoz
Inactive CompaniesAlcon (China) Ophthalmic Product Co Ltd
Active IndicationsOtitis Externa
Inactive IndicationsN/A

Other Information

ATC CodeS01CA03S02CA03S03CA04
Related LinksN/A